The results are qualitatively the same as those obtained using non-PVC data Fig 4, with increases in tau production along the AD progression timeline and a faster transport rate in A+T− subjects compared to A+T+ and A−T− subjects. This evidence concerns the gene MAPT and Alzheimer disease.